Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia A Double Blind, Placebo Controlled, Study in Diabetic and Non-diabetic Patients
Brief Summary: The investigators propose confirm and extend the findings of open studies on the apparent efficacy of bone-marrow derived mononuclear cells for the induction of arteriogenesis in patients with severe claudication or critical leg ischemia and pay special attention to the influence of diabetic disease on the outcome of the study and to the possible pro-atherogenic/ pro-inflammatory effects of BM-MNC injections.


Options:
A: Arm Label: BM-MNC; Type: EXPERIMENTAL; Interventions: Procedure: Bone marrow punction, Procedure: BM-MNC infusion | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Bone marrow punction, Procedure: Placebo infusion | Intervention Type: PROCEDURE; Name: Bone marrow punction; Assigned to Arm(s): BM-MNC, Placebo | Intervention Type: PROCEDURE; Name: BM-MNC infusion; Assigned to Arm(s): BM-MNC | Intervention Type: PROCEDURE; Name: Placebo infusion; Assigned to Arm(s): Placebo
B: Arm Label: Active/Treatment Group; Type: EXPERIMENTAL; Interventions: Biological: Allogeneic bone marrow derived mesenchymal stem cells | Arm Label: Observation Group 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Observation Group 2; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Observation Group 3; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control Group 4; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BIOLOGICAL; Name: Allogeneic bone marrow derived mesenchymal stem cells; Assigned to Arm(s): Active/Treatment Group
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Biological: bone marrow derived mononuclear cells | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: placebo | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Biological: bone marrow derived mononuclear cells | Arm Label: 4; Type: PLACEBO_COMPARATOR; Interventions: Biological: placebo | Intervention Type: BIOLOGICAL; Name: bone marrow derived mononuclear cells; Assigned to Arm(s): 1, 3 | Intervention Type: BIOLOGICAL; Name: placebo; Assigned to Arm(s): 2, 4
D: Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: bone marrow stem cells intraarterial; Type: ACTIVE_COMPARATOR; Interventions: Biological: bone marrow stem cells (BMC) | Arm Label: tissue repair cells intramuscular; Type: ACTIVE_COMPARATOR; Interventions: Biological: tissue repair cells (TRC) | Arm Label: tissue repair cells intraarterial; Type: ACTIVE_COMPARATOR; Interventions: Biological: tissue repair cells (TRC) | Arm Label: bone marrow stem cells intramuscular; Type: ACTIVE_COMPARATOR; Interventions: Biological: bone marrow stem cells (BMC) | Intervention Type: BIOLOGICAL; Name: tissue repair cells (TRC); Assigned to Arm(s): tissue repair cells intraarterial, tissue repair cells intramuscular | Intervention Type: BIOLOGICAL; Name: bone marrow stem cells (BMC); Assigned to Arm(s): bone marrow stem cells intraarterial, bone marrow stem cells intramuscular

Answer: C